Response Evaluation Criteria for Neuroendocrine Tumor Lesions on Somatostatin Receptor PET/CT after Peptide Receptor Radionuclide Therapy
Nuklearmedizin - NuclearMedicine · 01.03.2024 · 63 (02) · 145
DOI: 10.1055/s-0044-1782446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.03.2024. Verfasst von A. Chaban und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chaban, A., Song, Y., Dinkel, V., Eiber, M., Brosch-Lenz, J., Krebs, S., Bodei, L., & Weber, W. (2024). Response Evaluation Criteria for Neuroendocrine Tumor Lesions on Somatostatin Receptor PET/CT after Peptide Receptor Radionuclide Therapy. Nuklearmedizin - NuclearMedicine, 63(02), 145. https://doi.org/10.1055/s-0044-1782446
Vancouver
Chaban A, Song Y, Dinkel V, Eiber M, Brosch-Lenz J, Krebs S, et al. Response Evaluation Criteria for Neuroendocrine Tumor Lesions on Somatostatin Receptor PET/CT after Peptide Receptor Radionuclide Therapy. Nuklearmedizin - NuclearMedicine. 2024;63(02):145. doi:10.1055/s-0044-1782446
BibTeX
@article{Chaban2024,
author = {Chaban, A. and Song, Y. and Dinkel, V. and Eiber, M. and Brosch-Lenz, J. and Krebs, S. and Bodei, L. and Weber, W.},
title = {Response Evaluation Criteria for Neuroendocrine Tumor Lesions on Somatostatin Receptor PET/CT after Peptide Receptor Radionuclide Therapy},
journal = {Nuklearmedizin - NuclearMedicine},
year = {2024},
volume = {63},
number = {02},
pages = {145},
doi = {10.1055/s-0044-1782446}
}
EUVIMED